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Summary 
Dielectrophoresis (DEP) was used to examine a panel of MCF-7 cell lines comprising 
MDR derivatives: MCF-7TaxR (paclitaxel –resistant, P-glycoprotein (P-gp) positive), 
MCF-7DoxR (doxorubicin-resistant P-gp negative) plus MCF-7MDR1 (MDR1 
transfected, P-gp positive). MCF-7DoxR and MCF-7MDR1 were broadly cross-
resistant to natural product anticancer agents, whereas MCF-7TaxR cells were not, 
contrary to P-gp expression.  Whilst DEP revealed modest membrane changes in 
MDR sublines, we saw significant changes in their cytoplasmic conductivity: MCF-
7TaxR< MCF-7< MCF-7MDR1< MCF-7DoxR (range 0.14 - 0.40S/m).   Cytoplasmic 
conductivity is affected by the movement of molecules e.g. as in intracellular 
trafficking   MCF-7TaxR showed a reduced membrane potential, whereas MCF-
7DoxR and MCF-7MDR1 showed an increase.   Thus, altered membrane potential is 
associated with an MDR phenotype, but in a complex manner. DEP data suggest a 
model whereby relative increases in cytoplasmic conductivity are correlated with 
MDR, whilst relative decreases equate with a sensitised phenotype e.g. MCF-7TaxR. 
Moreover, extent of anthracycline accumulation was inversely related to cytoplasmic 
conductivity. These data are representative of a model where drug sensitivity is 
associated with low ionic conductance (reduced cellular trafficking and ion transport) 
and substantial anthracycline accumulation. For classical MDR i.e. MCF-7MDR1, we 
saw the reverse picture. Thus, the drug resistance phenotypes of this panel of MCF-7 
lines can be delineated by assessment of cytoplasmic biophysical properties using 
DEP. 
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Introduction 
It is a number of years since the first description of anticancer drug resistance [1], and 
since then many mechanisms have been described that attempt to explain the basis 
underlying this phenomenon. By far the most studied form of anticancer drug 
resistance is that of multidrug resistance (MDR), and findings from that research 
influenced to some extent research into MDR in microorganisms e.g. malaria and 
bacteria. Indeed, the cloning of MDR genes overexpressed in MDR tumour cells 
resulted in the discovery of a large family of membrane located glycoproteins- the 
ATP-binding cassette (ABC) proteins. The large majority of studies have focused on 
MDR1 protein, also referred to as P-glycoprotein (P-gp; recently renamed ABCB1). 
 
Previous work by Wadkins and Roepe and others [2] went to some lengths to try to 
understand mechanisms that give rise to the MDR phenotype. For example, alterations 
in the membrane potential and also alkalinisation of the cytoplasm were shown to be 
features of P-gp expressing cells that could go some way towards explaining their 
drug resistant phenotype [3; 4]. In this paper we set out to explain on the basis of 
biophysical parameters, the drug sensitivities of a panel of novel MCF-7 drug resistant 
cell lines: MCF-7TaxR, MCF-7DoxR and MCF-7MDR1. In terms of their molecular 
characterisation, we show that MCF-7TaxR expresses P-gp but unusually it fails to 
demonstrate a broad cross-resistance (or multiple resistance) to natural product 
anticancer agents. The paclitaxel resistance in that cell line is due to P-gp 
overexpression as the modulating agent XR9576 (P-gp specific) completely reverses 
the resistance. On the other hand, MCF-7DoxR does not express P-gp, MRP1 
(ABCC1) or BCRP (ABCG2) but shows broad cross-resistance to many natural 
product anticancer agents in line with an MDR phenotype. MCF-7MDR1 is a classical 
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MDR cell line showing both membrane P-gp overexpression and cross-resistance to 
natural product anticancer agents [5; 6]. 
 
It has been shown that cells transfected with MDR cDNA without subsequent 
maintenance in the presence of chemotherapeutic agents can certainly mimic some of 
the features of the MDR phenotype [7]. However, the level of drug resistance seen in 
those cells is somewhat less than that seen in drug-selected lines with comparable 
levels of P-gp expression.  Moreover, in terms of understanding the biophysical 
events associated with MDR it is clear that data obtained using ‘pure’ transfected 
models are somewhat at variance with those obtained using cells cultured in a drug 
containing environment. We have focused on the latter as our model system – which 
used a panel of cell lines including an MCF-7MDR1 transfected line but also 
maintained in a drug conditioned environment and, hence, not representative of a 
‘pure’ transfection model. In terms of what is entirely relevant to the problem of 
clinical drug resistance and, hence, the ideal model has yet to be agreed upon by the 
cancer research community. Whilst it is imperative to define the effect of the MDR1 
gene expression itself on anticancer drug resistance, it is also important to understand 
those processes that bring about a drug-induced MDR phenotype. Acquired MDR 
phenotypes are well-documented phenomena and are highly relevant to the 
development of clinical drug resistance. Elegant studies such as those by Hoffman et 
al. [7] have been very important in helping us to understand a more precise role for 
MDR1 in anticancer drug resistance. Notwithstanding, we propose that using cell line 
models with acquired drug resistant phenotypes obtained by growing up in a drug 
containing environment must bear some relation to the heavily pre-treated tumours 
that present with MDR in the clinic. Criticism of use of these types of cell line models 
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has focused on the very high levels of drug resistance seen (sometimes in excess of 
1000-fold) which have been deemed by many to be totally irrelevant to the problem of 
clinical drug resistance where 2-fold resistance to an anticancer agent will result in 
disease progression and kill the patient. We have used cell lines with relatively 
modest levels of drug resistance, maintained using drug doses relevant to clinically 
achievable blood levels. 
 
Primarily, we have used the technique of dielectrophoresis (DEP) to understand the 
biophysical nature of the MCF-7 cell line panel, including the parental cells. DEP is a 
technique whereby the frequency-dependent behaviour of cells is determined in non-
uniform electric fields, and from this information regarding the electrical properties of 
the cell can be inferred [8; 9; 10].  DEP and related techniques have been used to 
characterise a wide range of cellular processes in terms of these biophysical properties 
in cancer research [11-18]. Our studies have also incorporated a flow cytometric 
technique to measure membrane potential as an additional biophysical parameter to be 
considered in our assessment of the cell line panel. Previously we have shown that 
due to the nature of the putative drug efflux mechanism employed by MDR cells, dye-
based methods of analysis (e.g. using DIOC5) to assess membrane potential can yield 
misleading results [19].  However, by combined use of an MDR modulating agent that 
corrects for defective DIOC5 accumulation that is recognised by ABC transporters, 
we can achieve a more realistic interpretation of membrane potential in an MDR cell 
line. We have also looked at the cellular accumulation of anthracyclines in our MCF-7 
panel of lines, using fluorescence microscopy. These data have highlighted a close 
association between cytoplasmic conductivity and extent of drug accumulation in the 
present study. 
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We demonstrate that there are significant changes in the cytoplasmic conductivity of 
all MDR cell lines relative to the parent line and also to each other.  Interestingly, 
there are membrane changes measured using DEP seen for the paclitaxel-resistant line 
in terms of the membrane capacitance (Cspec) and not observed for either the 
doxorubicin-resistant or MDR1 transfected MCF-7 lines. In addition, in line with its 
overall drug sensitivity profile, the MCF-7TaxR cell line is proficient in anthracycline 
accumulation, which is counterintuitive to the presence of membrane P-gp.  Based on 
the present data, we can propose a model based on biophysical factors that can explain 
MDR whether in the absence or presence of Pgp or other ABC transporters. 
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Materials and Methods 
Chemicals and reagents 
Paclitaxel (Taxol; obtained from Bristol Myers Squibb UK as a pharmacy 
preparation) and doxorubicin (Sigma Aldrich, Poole, UK) were dissolved in either 
sterile 0.9% NaCl solution (paclitaxel) or in sterile distilled water (doxorubicin). They 
were stored frozen as stock solutions and were thawed prior to use. DIOC5 (obtained 
from Molecular Probes, Invitrogen, Paisley, UK) was made up as an aqueous stock 
solution and stored at -20o C until use. XR9576 (kindly provided by Xenova PLC, 
Slough, UK) was made up as a stock solution in DMSO and stored frozen until use. 
PSC-833 (Valspodar; obtained from Novartis, Basel, Switzerland) was made up as a 
5mM stock solution in ethanol, stored at -20o C and then diluted accordingly for use 
in experiments. 
 
Cell culture 
All cell culture reagents were obtained from Sigma Aldrich (Poole, UK), unless stated 
otherwise. The MCF-7 human breast cancer cell line and its paclitaxel and 
doxorubicin resistant counterparts MCF-7TaxR and MCF-7DoxR, respectively were 
grown in 20mM HEPES modified Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 10% heat-inactivated foetal calf serum (FCS), (Invitrogen, Paisley, 
UK) and 2mM L-glutamine. The cells were grown under standard incubation 
conditions at 37C.  Both the drug resistant cell lines were derived in our laboratories 
by growing up in increasing step-wise concentrations of the inducing agent for a 
number of weeks until a stable resistance phenotype was achieved. MCF-7TaxR was 
maintained in the presence of 6nM paclitaxel, while MCF-7DoxR was maintained in 
the presence of 100nM doxorubicin.  The MCF-7MDR1 cell line, kindly provided by 
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Professor Robert Clarke, Georgetown University, Washington DC, US, was stably 
transfected with the MDR1 gene and maintained with selection pressure using 
200ng/ml colchicine [20] The parental MCF-7 breast cancer cells were obtained from 
The European Collection of Cell Culture, Porton Down, Salisbury, UK (ECACC). All 
cultures were regularly checked for mycoplasma infection. 
 
Chemosensitivity testing 
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was used to 
titrate cell viability following drug treatment, as described by Mosmann [21]. MCF-7 
cells were seeded at a density of the order of 2-4x104 cells/ml (dependent upon 
doubling times of the particular cell lines) in supplemented tissue culture medium (see 
above). Cells were then dispensed into 96-well plates in volumes of 200L and left to 
equilibrate for 24 hours at 37C and 5% CO2. Freshly thawed stock drug solutions 
were diluted in complete tissue culture medium and added at the appropriate 
concentration. Control wells containing cell suspension were supplemented with a 
similar volume of culture medium only. The MDR reversal agent XR9576 was used 
in combination with paclitaxel in the MCF-7TaxR line and in combination with 
doxorubicin in the MCF-7DoxR and MCF-7MDR1 lines in order to ascertain whether 
resistance was attributable to P-gp. XR9576 was used at a final concentration of 
100nM, in line with previous studies [22]. In addition, for some experiments we 
incorporated the use of PSC-833 at a final concentration of 5M (as previously 
described in [23]) as a broad spectrum MDR modulator particularly to see if there was 
any modulation of resistance in the MCF-7DoxR cell line due to hitherto unidentified 
ABC transporters. 
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Following 96-hour incubation, cultured cells were treated with 20 L of 5mg/mL 
MTT in PBS (Sigma Aldrich, UK) for 4 hours at 37o C.  Wells were then aspirated 
dry and the tetrazolium crystals dissolved in 200L of DMSO.  Absorbance was read 
at 540nm using an automated ELISA plate reader. The results were expressed as IC50, 
i.e. the concentration of cytotoxic drug that reduces cell viability by 50% relative to 
the control (untreated cells). 
 
Western immunoblotting 
Crude cell membrane preparations were made from monolayers of cultured cells in 
the exponential phase of growth. Following detachment of cells using non-enzymatic 
cell dissociation fluid, cells were pelleted and washed twice in PBS and then 
resuspended in hypotonic lysis buffer containing detergent and protease inhibitors. 50 
g of membrane protein was loaded onto a 10% acrylamide SDS and resolved by 
SDS-PAGE. The presence of P-gp was detected with anti-P-gp rabbit polyclonal 
antibody, clone H241; MRP1 was detected using clone C-20 goat polyclonal antibody 
(both from Autogen Bioclear, Calne, UK) and BCRP was detected using clone Ab-1 
mouse monoclonal antibody (CN Biosciences, Beeston, Nottingham, UK). 
Visualisation was carried out using the appropriate species HRP conjugated with a 
secondary antibody with chemiluminescence (Perbio Science UK Ltd, Cheshire, UK) 
compared to standard molecular weight markers (Invitrogen, Paisley, UK).  
 
Measurement of membrane potential using DIOC5 
MCF-7 cell lines were trypsinized and resuspended in complete medium to a density 
of 106 /ml. The chemosensitizers XR9576 and PSC-833 were used as in the 
chemosensitivity experiments. The membrane potential sensitive dye DIOC5 was 
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added to the cell suspension at a final concentration of 5M. The dye was substituted 
with media in control untreated samples. After incubating at 37C for 30min (with or 
without XR9576) fluorescence signals using FL1 (525nm, green fluorescence), 
associated with membrane potential, were measured using the Coulter Epics XL flow 
cytometer. Each experiment was set up on at least 3 separate occasions. The data were 
assessed according to the calculated geometric means of the peaks obtained using the 
WinMDI 2.8 program. 
 
DEP experiments 
The drug resistant and sensitive cells were centrifuged at room temperature at 200g 
for 5 minutes. The pellets were washed and resuspended in isotonic medium 
consisting of 8.5% (w/v) sucrose plus 0.3% (w/v) dextrose buffer. The medium 
conductivity was adjusted to 2.5 mS/m using PBS and the final conductivity, before 
use, was verified with a conductivity meter (RS components Ltd, London, UK). The 
final cell population was counted using a haemocytometer and adjusted to 
approximately 3x105 cells/ ml (15%).  Experiments were repeated 4-6 times with 
different populations, which were summed prior to modelling. The experimental set 
up and detailed methodology are described elsewhere [19].  Parameters were derived 
using a single-shell model and fitted according to the mathematical model described 
by Broche et al. [ref]. 
 
Preparation of cells for fluorescence microscopy: 
Single cell suspensions were prepared as for chemosensitivity testing. Sterile glass 
cover-slips were placed in sterile tissue culture treated dishes to form a single layer. 
Single cell suspensions of the various MCF-7 cell lines were pipetted directly onto the 
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coverslips in the dishes and allowed to settle for 24h in standard tissue culture 
conditions. Dishes were aspirated dry and then Doxorubicin or daunorubicin 
containing tissue culture medium at a concentration of 50µM was added to each dish 
in a volume of 10ml for 2 hours at 37 oC. These culture conditions have been used 
previously and 2 hours is sufficient for steady-state levels to be achieved. The drug-
containing medium was then aspirated and the monolayers washed with cold PBS 
twice. Coverslips were then placed face down onto clean microscope slides and 
viewed using green fluorescence microscopy at 488nm 
 
Results 
Chemosensitivity Testing:    
Figure 1 depicts the cross-resistance profile for the MCF-7 drug resistant cell lines 
used in this study alongside Table 1 indicating the IC50 values used to derive the 
figure. MCF-7DoxR with approximately 5-fold doxorubicin resistance showed a 
broad cross-resistance to natural product anticancer drugs of varying mechanism of 
action. Hence, MCF-7DoxR had a cross-resistance profile in keeping with a classical 
MDR phenotype with moderate levels of drug resistance. The mean IC50 value 
obtained for MCF-7DoxR with a combination of doxorubicin and PSC-833 was 
indicated in the footnote to Table 1. This result was not significantly different from 
the values obtained with doxorubicin alone (p = >0.1). We performed additional 
experiments incorporating XR9576 with the MCF-7DoxR line and found no 
significant variation from control values (data not shown). There was no evidence for 
the presence of MDR transporter activity in the MCF-7DoxR cell line based on the 
chemosensitivity data incorporating MDR modulators as no change in drug sensitivity 
was seen. In contrast, the MCF-7TaxR cell line with approximately 17-fold resistance 
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to paclitaxel showed residual or no cross-resistance to the same natural product 
anticancer agents. The resistance of MCF-7TaxR to paclitaxel was completely 
reversed by XR9576 (giving an IC50 value of 4.0nM s.d.+/- 1.5, p= <0.02). We can, 
therefore, attribute the paclitaxel resistance in MCF-7TaxR cells to be entirely due to 
the presence of P-gp as XR9576 completely reversed the resistance in this cell line 
variant. The MCF-7MDR1 line [20] was shown to be approximately 30-fold resistant 
to doxorubicin and, hence, was the most drug-resistant cell line in the panel. The 
doxorubicin resistance was significantly reversed by XR9576, as noted in Table 1. 
 
Detection of MDR-associated proteins 
In addition to the data obtained using the MTT assay, Western immunoblotting 
(Figure 2) revealed the expression of the MDR protein, P-gp in the resistant breast 
cancer cell line MCF-7TaxR and MCF-7MDR1 lines but not in MCF-7DoxR cells. 
Moreover, MCF-7TaxR, MCF-7MDR1 and MCF-7DoxR were shown to be devoid of 
MRP1 over-expression and levels of BCRP expression for the entire panel were 
shown to be very similar. 
 
Assessment of membrane potential using DIOC5 
The corrected peak mean fluorescence of cells incubated with DIOC5 with or without 
XR9576, relative to the values for MCF-7 parental cells are shown in Table 3. Data 
shown are representative of several repeat experiments using duplicate or triplicate 
analyses of each sample. Overall, both the MCF-7 drug resistant variants showed 
lower membrane potentials than parental cells, even with correction for artefactual 
transport of DIOC5 by use of XR9576. In line with the chemosensitivity data, it can 
be seen that XR9576 can modulate DIOC5 accumulation in MCF-7TaxR cells as FL1 
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associated fluorescence was shown to increase when this compound was incorporated 
into the incubation medium. Moreover, the effects of XR9576 on the data obtained for 
MCF-7DoxR were shown to be marginal, in agreement with the chemosensitivity data 
(data not shown). Data obtained using PSC-833 with MCF-7DoxR were similarly 
unaltered 
 
DEP Analysis 
In order to determine the electrical properties of populations, we have counted the 
number of cells collecting at the electrodes over a period of 1 minute of exposure to a 
field of a given frequency.  This was performed over a range of frequencies from 
5kHz-20MHz at 5 frequencies per decade, and modelled using a single-shell model to 
fit parameters as outlined by Broche et al [ref1].  The fitted parameters were the 
conductance and capacitance of the membrane, and the conductivity of the cytoplasm, 
plus a scaling factor; in the frequency window used, it is not possible to obtain 
accurate data for the cytoplasmic permittivity.  Radius data were taken by measuring 
cell diameters with a microscope and image analysis software. The experiments were 
repeated four times and the aggregate collection was used.  A summary of the data 
obtained is contained in Table 2. In line with the expression of membrane P-gp, MCF-
7TaxR cells show an increase in specific membrane capacitance (Cspec ) suggestive of 
increases in membrane folding and/or changes in membrane morphology. For MCF-
7DoxR and MCF-7MDR1 there was little variation in this parameter when compared 
to MCF-7 parental cells. As the other P-gp expressing line in the panel did not show 
an increase in membrane capacitance it appears that a rise in this parameter is more a 
consequence of the increased ruffled appearance seen under light microscopy for 
MCF-7TaxR, rather than an increase in membrane ABC transporter expression (data 
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not shown). The most striking variation in the data was in the cytoplasmic 
conductivity (), where the value for MCF-7TaxR is much lower than parental MCF-
7 cells (0.14 and 0.23 S/m, respectively), whereas MCF-7MDR1 and more so MCF-
7DoxR cells show a marked increase (0.4 S/m) in this parameter. It is possible that 
changes in viscosity (and hence ion mobility) in cytoplasms with different ionic 
strengths (in order to maintain osmotic balance) may affect these parameters [ref2].  
However, taking cytoplasmic conductivity and plasma membrane potential data 
together plotted for the 4 individual cell lines in the panel, we can see from Figure 2 
that a linear relationship exists between these 2 parameters, with a positive correlation 
being seen- Pearson’s coefficient of correlation = 0.88, indicating a high likelihood 
that such effects are relatively small. 
 
Fluorescence microscopy for anthracycline accumulation 
Figure 3 shows anthracyline accumulation for all four cell lines in the panel. 
Compared with the parental MCF-7 cells, the MCF-7DoxR line shows several areas 
of groups of cells with weak fluorescence due to defective accumulation. For the 
MCF-7MDR1 cells, the areas of hypo-fluorescent cells are the most apparent for the 
series. In contrast, the MCF-7TaxR cells are highly fluorescent, with pockets of 
intense fluorescence. Compared with the picture seen for MCF-7 parental cells, the 
extent of drug accumulation seen for MCF-7TaxR is very similar. In summary the 
order of anthracycline accumulation in the cell line panel is MCF-7 > MCF-7TaxR > 
MCF-7DoxR > MCF-7MDR1. 
 
. 
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DISCUSSION 
The majority of MDR cell lines that have been described in the literature over the past 
25 years or more possess phenotypes that are likely to be the summation of many drug 
resistance mechanisms including (but not exclusively) MDR. However, all these 
models describe a drug resistance mechanism for which defective drug accumulation 
is the major factor defining that phenotype.  
 
In order to appreciate better the mechanisms underlying the drug resistance profiles of 
the MCF-7DoxR and MCF-7TaxR lines we undertook a series of biophysical studies 
using DEP and flow cytometry. The most significant findings of our study relate to 
cytoplasmic conductivity and also to membrane potential. Here we make the case that 
P-gp overexpression, as seen in MCF-7TaxR cells, does not appear to influence the 
level of MDR in those cells, as they are distinctly non- cross-resistant with natural 
product anticancer agents. The factor that appears to dictate the drug sensitivity / 
resistance profile in our panel of cells is more closely related to changes in 
biophysical character that have been assessed using DEP and DIOC5 with flow 
cytometric analysis. We also show that drug sensitivity, dictated by reduced or low 
cytoplasmic conductivity, is associated with high levels of cellular drug accumulation, 
as seen with the anthracyclines.  
 
Plasma membrane potential has frequently been cited as a critical factor underlying 
anticancer MDR, although there is inconsistency in the literature.  We have previously 
demonstrated flow cytometric studies of membrane potential using DIOC5 with MDR 
cancer cell lines may produce artefactually low values due to defective accumulation 
of the dye as a possible consequence of the MDR pump activity, in agreement with 
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others [19; 24; 25]. Membrane potential measurements were made in the presence of 
XR9576, as previous studies have indicated that the membrane potential sensitive dye 
DIOC5 is a substrate for Pgp-mediated transport [19; 24]. Our data indicate MCF-
7TaxR as having a lower membrane potential than MCF-7DoxR or MCF-7MDR1, 
with those for the parental cells lying somewhere in between. Interestingly, MCF-
7TaxR cells with the lowest membrane potential and lowest cytoplasmic conductivity 
were overall the most drug sensitive in spite of the presence of membrane P-gp 
(conferring selective resistance to paclitaxel). An increase in cytoplasmic conductivity 
could occur as a consequence of increased cytoplasmic molecular transport - 
intracellular trafficking, which is associated with MDR [26; 27].  
 
Here we make the case that P-gp overexpression, as seen in MCF-7TaxR cells, does 
not appear to influence the level of MDR in those cells, as they are distinctly non- 
cross-resistant with natural product anticancer agents. The factor that appears to 
dictate the drug sensitivity/resistance profile in our panel of cells is more closely 
related to changes in biophysical character measured by DEP. A report by Aleman et 
al. [28] compared MDR1 transfected models with drug-selected variants of HeLa. The 
data indicated that drug selected cells were relatively hyperpolarized when compared 
to transfected or parental cells, in line with our data obtained for MCF-7DoxR and to 
some extent for MCF-7MDR1.  In contrast, the report by Hoffman et al. [7] indicated 
a reduced membrane potential and hence a hypopolarised state for a ‘pure’ MDR1 
transfected cell line (i.e. having never been exposed to chemotherapeutic agents).  It 
should be noted that that particular cell line model showed a low, approximately 2-
fold level of drug resistance and this may have resulted in very subtle changes that 
may not have been so evident in the data obtained. 
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The surface conductance of the plasma membrane indicated by the parameter Ks was 
shown to be markedly altered (reduced) from parental MCF-7 cells in the MCFMDR1 
cells, with insignificant changes being seen for the other lines in the panel. MDR1 Pgp 
has been proposed to change lipid-protein interactions on the intramembranous 
surface of the transporter. This may be brought about by changes in distribution of 
types of lipids (e.g. glucosylceramide) between the inner and outer leaflets of the 
plasma membrane giving rise to altered dipole potentials [29]. Such changes may be 
relevant to our transfected cell line model, but were not apparent for the MCFTaxR P-
gp expressing cells. 
 
The membrane capacitance values obtained in our study place non-ABC transporter 
expressing MCF-7 and MCF-7DoxR (values 12.4 mF/m2) as cells with relatively 
smooth plasma membranes [30] which quotes values of approximately 10mF/m2 .  
The markedly increased value in capacitance (Cspec) seen for MCF-7TaxR, the 
smallest cell line in the panel in terms of the cell radius measurements, was also 
associated with a more noticeably ruffled appearance to its membrane under light 
microscopy. Reasons for increases in membrane capacitance are known to be 
membrane folding and exocytotic activity, such as that seen for the white blood cell 
lineage the eosinophil [31]. It has long been established that a membrane located 
protein can be expected to influence the capacitance of that membrane. Furthermore, 
it is known that the function of membraneous protein is regulated by the electrical 
potential of that membrane. This may be relevant for MCF-7TaxR where we see a 
hypopolarised state in spite of the presence of P-gp. The influence of a reduced 
plasma membrane potential and /or the reduced cytoplasmic conductivity (as 
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discussed below) in the paclitaxel-resistant cells MCF-7TaxR appeared to modulate 
the activity of Pgp within these cells so as to render it ineffective in modulating 
sensitivity and transport of MDR-type substrates, such as doxorubicin, colchicine and 
VP-16. There is also the possibility that MCF-7TaxR cells express a mutant form of 
Pgp. However, this is unlikely as the cells were rendered sensitive to MDR 
modulation and expressed epitopes recognised by antibodies to Pgp.  
 
The technique of DEP provides a measure of the ionic state of cells, indicating the 
total free (mobile) ionic content of the cytoplasm. Our data indicate a state of low 
ionic content in MCF-7TaxR cells (0.14S/m) with respect to the parental MCF-7 cells 
(0.23S/m). Conversely in MCF-7DoxR, the cytoplasmic conductivity was 
approximately double (0.4S/m) that seen for the parental line (0.23S/m). Other 
mechanisms underlying MDR have been suggested in the literature, including the 
protonation and sequestration of drugs in vesicles [26] and the possibility of altered 
pH gradients with respect to the parent line [32].  A report by Raghunand et al. [33] 
described a mathematical model that demonstrates reduced cellular drug accumulation 
in non-P-gp expressing cells as being due to the activity of an organic cation/H+ 
antiporter within endosomal membranes. This may form the basis of a number of 
mechanisms that can result in reduced drug accumulation such as active transport of 
drug into endosomes (reducing drug levels in the perinuclear region), decreased 
endosomal pH and increased plasma membrane pH gradient. We are uncertain as to 
the relevance of these mechanisms in our cell line panel, but the increased cytosolic 
conductivity may be indicative of the processes by which the cytoplasmic pH is 
altered. However, as we have not measured the intracellular pH in our cell line panel 
we are uncertain as to its role in mediating an MDR phenotype. Moreover, data in the 
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literature are somewhat conflicting with regard to the role of intracellular pH and the 
MDR phenotype. We propose a model whereby a decrease in ionic content brings 
about concomitant decrease in trafficking processes, thus facilitating drug 
accumulation and retention via passive diffusion. 
 
Many chemotherapeutic agents to which MDR cells are resistant are not cationic in 
nature, but are weakly basic. Hence, it has been argued that changes in membrane 
potential should not lead to significant changes in the trans-membraneous distribution 
of those drugs in MDR cells. Paclitaxel itself is not a weakly basic drug as in the case 
of doxorubicin (pKa 8.2) or etoposide (pKa 9.7). It possesses multiple molecular sites 
with overall no ionisable groups, so is an uncharged molecule. However, it has been 
reported that an acidic pH may enhance microtubular stabilization by paclitaxel [34]. 
Thus, if MCF-7TaxR cells have an alkaline intracellular pH then this may go some 
way to explain the basis for their resistance. However, this should also coincide with 
resistance to colchicine as a more acidic pH is more favourable for binding of the drug 
to tubulin [35]. Clearly, this is not the case for MCF-7TaxR, as shown by its lack of 
cross-resistance to colchicine. The narrow and selective resistance profile of MCF-
7TaxR, in spite of the presence of P-gp overexpression, may be explained by 
significant changes in the cytoplasmic nature of the MCF-7TaxR cells, reflected in the 
low cytoplasmic conductivity. We also accept that there may be other molecular 
features ascribable to the MCF-7TaxR cell line that result in a cell line that is overall 
sensitive to many chemotherapeutic agents.  However, the current study set out to 
investigate the biophysics of MDR using this model as a tool to clarify the role of P-
gp and other factors in this drug resistance phenotype. 
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In conclusion, we propose that there are marked differences in the 
electrophysiological character between MCF-7 and MDR derivative lines developed 
under selection pressure, and between the different MDR lines themselves when 
developed from different anti-cancer drug selection pressure.  The cell line models 
themselves indicate that overexpression of ABC transporter protein is not necessarily 
a prerequisite for the MDR phenotype. We propose that marked differences in the 
nature of the cytoplasm in terms of the conductance measured using DEP go some 
way towards explaining the relative drug sensitivities of the cell lines. We propose 
that the technique of DEP may be useful in identifying populations of tumour cells 
with differing cell sensitivities on the basis of cytoplasmic conductivity 
measurements. Moreover, the present study highlights the utility of DEP as an 
effective cell separation technique. 
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TABLE 1 
 
Chemosensitivity testing in MCF-7 cell lines using the MTT assay (continuous 
drug exposure) 
 
 
 
COMPOUND 
 
CELL LINE IC50 VALUES 
 
   MCF-7               MCF-7TaxR         MCF-7DoxR    MCF-7MDR-1 
 
Paclitaxel (nM) 
 
 
5.3 (2.4) 
 
74.4* (18.3) 
 
57.0 (26.3) 
 
ND 
 
Doxorubicin (nM) 
 
 
113 (40.7) 
 
127.5 (38.5) 
 
656# (199) 
 
3162$ (228) 
 
Etoposide (uM) 
 
 
6.4 (5.2) 
 
7.8 (3.9) 
 
54.5 (12.3) 
 
ND 
 
Colchicine (nM) 
 
 
174 (53.5) 
 
258.5 (80.5) 
 
878 (379) 
 
ND 
 
 
 
 
 
 
 
 
 
Footnote to Table 1: 
  29 
Figures shown are the means of IC 50 values for at least 4 separate experiments with 
the standard deviation shown in parentheses 
 
* Mean IC 50 value obtained for MCF-7TaxR with paclitaxel in combination with 
XR9576 = 4.0nM (sd=1.5) 
 
# Mean IC 50 value obtained in combination with PSC-833 = 702nM (sd=33) 
 
$Mean IC 50 value obtained in combination with XR9576= 222 nM (s.d. 52) 
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TABLE 2 
 
Derived dielectric data for MCF-7 cell lines using a best-fit procedure to match 
the polarizability spectrum to the observed dielectrophoretic behaviour of 
particles. 
 
 
 
CELL LINE 
 
CYTOPLASM 
 (S/m) 
MEMBRANE 
 
   KS (pS)             Cspec 
(mF/m2) 
 
MCF-7 
 
 
0.23 + 0.01 
 
    11 + 2               12.4 + 1.8 
 
MCF-7TaxR 
 
 
0.14+ 0.01 
 
    10 +2              20.6 + 1.1 
 
MCF-7DoxR 
 
 
0.40 + 0.02 
 
     9 + 2                12.4 + 0.9 
 
MCF-7/MDR1 
 
 
0.27 + 0.02 
 
    6 + 1                12.6 + 0.7 
 
 
Figures shown are the means of >4 repeat experiments with the limits of best fit 
indicated. 
 
 (S/m) = conductivity 
 
KS (pS) = surface conductance 
 
Cspec (mF/m
2) =  capacitance
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TABLE 3 
 
Data showing flow cytometric analysis of MCF-7 cell lines using the membrane 
potential sensitive dye DIOC5 
 
 
 
Cell Line 
DIOC5 
shift 
(FL1)* 
DIOC5 shift 
+XR9576#/ 
PSC833$ 
Modulation 
factor‖ 
DIOC5 shift 
relative to 
MCF-7 
 
Interpretation 
 
MCF-7 
 
 
100 
 
 
107/108 
(4/15) 
 
1.07 
(0.04) 
 
1.00 
Control 
 
parental cells 
 
(Pgp –ve) 
 
MCF-7TaxR 
 
 
44 
 (8.5) 
 
69# 
(15) 
 
1.51 
(0.2) 
 
0.64 
Lowered 
 
membrane 
 
potential (Pgp +ve) 
 
MCF-7DoxR 
 
139 
(20.8) 
 
137$ 
(31) 
 
0.97 
(0.07) 
 
 
1.27 
Increased 
 
membrane 
 
potential 
 
(Pgp –ve) 
 
MCF-7/MDR1 
 
103 
(12.1) 
 
135# 
(5) 
 
1.31 
(0.09) 
 
1.25 
Increased 
 
membrane 
 
potential 
 
(Pgp +ve) 
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Footnote to Table 3: 
a Denotes FL1 signal corrected relative to MCF-7 which is set at 100 
# Denotes modulation due to the presence of 100nM XR9576 
$  Denotes modulation due to the presence of 4uM PSC-833 
‖ Denotes modulation of fluorescence intensity at FL1 due to modulation calculated as 
DIOC5 shift in presence of modulator / DIOC5 alone. 
 
Figures in parentheses are the standard deviation for >3 repeat experiments. 
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Legends to Figures 
 
 
Figure 1.  
Western blot to demonstrate the expression of the MDR proteins (P- glycoprotein) in 
MCF-7 cell lines. Membrane preparations for each cell line were loaded at a 
concentration of 40-50g of protein onto SDS PAGE 10% gels with a bis-tris running 
buffer system. Equivalent loading was checked by stripping the membrane after each 
Western was run for the individual MDR protein and then re-probed using an anti-
beta actin antibody (Ab-1) (obtained from CN Biosciences, Beeston, UK). The figure 
shows reprobing of a blot for beta actin when the blot had been stripped following 
probing with the primary antibody for MRP. This process was repeated for the other 
membranes probed with the primary antibodies for P-gp and for BCRP. The positive 
control for Pgp was the K562AR (doxorubicin-resistant cell line); for BCRP the T8 
cell line was used; for MRP the HL-60AR cell line was used (see Methods). 
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Figure 2. 
Plot of DIOC5 shift (y) versus cytoplasmic conductivity (x) showing a linear 
relationship for the two parameters in MCF-7 cell lines with MDR. Pearson’s 
correlation coefficient r = 0.88. 
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Figure 3. 
Fluorescence microscopy images of MCF-7 cell lines following 2h incubation with  
 
anthracycline. 
 
